Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Dong-A ST Co., Ltd. (170900.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
50,800.00-100.00 (-0.20%)
As of 11:08AM KST. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close50,900.00
Open50,900.00
Bid50,700.00 x 0
Ask50,900.00 x 0
Day's Range50,500.00 - 51,000.00
52 Week Range48,400.00 - 76,500.00
Volume775
Avg. Volume6,056
Market Cap428.806B
Beta (5Y Monthly)1.01
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateOct 31, 2022 - Nov 04, 2022
Forward Dividend & Yield1,000.00 (2.01%)
Ex-Dividend DateDec 29, 2021
1y Target Est82,400.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 170900.KS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Benzinga

      NeuroBo Shares Surge On Licensing, Equity Investment Pact With Korean Pharma Firm

      Dong-A ST, a pharmaceutical company in South Korea, has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo Pharmaceuticals Inc (NASDAQ: NRBO). Dong-A ST said it is in charge of samples for clinical trials and production after commercialization, while NeuroBo is responsible for clinical development, regulatory submission, and sales. The Korean company will receive a

    Advertisement
    Advertisement